These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8558438)

  • 1. Cationized hyperimmune immunoglobulins: pharmacokinetics, toxicity evaluation and treatment of human immunodeficiency virus-infected human-peripheral blood lymphocytes-severe combined immune deficiency mice.
    Pardridge WM; Kang YS; Diagne A; Zack JA
    J Pharmacol Exp Ther; 1996 Jan; 276(1):246-52. PubMed ID: 8558438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of human immunodeficiency virus-infected lymphocytes with cationized human immunoglobulins.
    Pardridge WM; Buciak J; Yang J; Diagne A
    J Infect Dis; 1994 Sep; 170(3):563-9. PubMed ID: 8077712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxicity, biological activity, and pharmacokinetics of TXU (anti-CD7)-pokeweed antiviral protein in chimpanzees and adult patients infected with human immunodeficiency virus.
    Uckun FM; Bellomy K; O'Neill K; Messinger Y; Johnson T; Chen CL
    J Pharmacol Exp Ther; 1999 Dec; 291(3):1301-7. PubMed ID: 10565855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocaine enhances human immunodeficiency virus replication in a model of severe combined immunodeficient mice implanted with human peripheral blood leukocytes.
    Roth MD; Tashkin DP; Choi R; Jamieson BD; Zack JA; Baldwin GC
    J Infect Dis; 2002 Mar; 185(5):701-5. PubMed ID: 11865430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy with low-dose interleukin-2: rationale for prevention of immune-deficiency-associated cancer.
    Khatri VP; Baiocchi RA; Bernstein ZP; Caligiuri MA
    Cancer J Sci Am; 1997 Dec; 3 Suppl 1():S129-36. PubMed ID: 9457408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.
    Garaci E; Aquaro S; Lapenta C; Amendola A; Spada M; Covaceuszach S; Perno CF; Belardelli F
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8927-32. PubMed ID: 12853577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Human peripheral blood CD4+ T-lymphocytes reconstituting severe combined immunodeficient mouse-human cell immune system and its immunological function].
    Zeng QH; Wang W; Liu T; Shi Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 29(5):513-6. PubMed ID: 16137035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of human immunodeficiency virus (HIV) human hyperimmune immunoglobulin in HIV type 1-infected children (Pediatric AIDS clinical trials group protocol 273).
    Stiehm ER; Fletcher CV; Mofenson LM; Palumbo PE; Kang M; Fenton T; Sapan CV; Meyer WA; Shearer WT; Hawkins E; Fowler MG; Bouquin P; Purdue L; Sloand EM; Nemo GJ; Wara D; Bryson YJ; Starr SE; Petru A; Burchett S
    J Infect Dis; 2000 Feb; 181(2):548-54. PubMed ID: 10669338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations of the human-PBL-SCID mouse model for vaginal transmission of HIV-1.
    D'Cruz OJ; Uckun FM
    Am J Reprod Immunol; 2007 May; 57(5):353-60. PubMed ID: 17430499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligands of the antiestrogen-binding site are able to inhibit virion production of human immunodeficiency virus 1-infected lymphocytes.
    Mesange F; Delarue F; Puel J; Bayard F; Faye JC
    Mol Pharmacol; 1996 Jul; 50(1):75-9. PubMed ID: 8700122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of HIV-1 epitopes that induce the synthesis of a R5 HIV-1 suppression factor by human CD4+ T cells isolated from HIV-1 immunized hu-PBL SCID mice.
    Yoshida A; Tanaka R; Kodama A; Yamamoto N; Ansari AA; Tanaka Y
    Clin Dev Immunol; 2005 Dec; 12(4):235-42. PubMed ID: 16584108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent anti-R5 human immunodeficiency virus type 1 effects of a CCR5 antagonist, AK602/ONO4128/GW873140, in a novel human peripheral blood mononuclear cell nonobese diabetic-SCID, interleukin-2 receptor gamma-chain-knocked-out AIDS mouse model.
    Nakata H; Maeda K; Miyakawa T; Shibayama S; Matsuo M; Takaoka Y; Ito M; Koyanagi Y; Mitsuya H
    J Virol; 2005 Feb; 79(4):2087-96. PubMed ID: 15681411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene therapy using a simian virus 40-derived vector inhibits the development of in vivo human immunodeficiency virus type 1 infection of severe combined immunodeficiency mice implanted with human fetal thymic and liver tissue.
    Goldstein H; Pettoello-Mantovani M; Anderson CM; Cordelier P; Pomerantz RJ; Strayer DS
    J Infect Dis; 2002 May; 185(10):1425-30. PubMed ID: 11992277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of safety and efficacy of RNAi against HIV-1 in the human immune system (Rag-2(-/-)gammac(-/-)) mouse model.
    ter Brake O; Legrand N; von Eije KJ; Centlivre M; Spits H; Weijer K; Blom B; Berkhout B
    Gene Ther; 2009 Jan; 16(1):148-53. PubMed ID: 18668146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reconstitution of Hu-SCID mice transplanted with human tonsillar lymphocytes immunized with dengue virus-2 in vitro and its immune response].
    Zuo L; Guo H; Zhang C
    Zhonghua Yi Xue Za Zhi; 1996 Aug; 76(8):597-9. PubMed ID: 9275474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse.
    Roth MD; Tashkin DP; Whittaker KM; Choi R; Baldwin GC
    Life Sci; 2005 Aug; 77(14):1711-22. PubMed ID: 15964028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cocaine and sigma-1 receptors modulate HIV infection, chemokine receptors, and the HPA axis in the huPBL-SCID model.
    Roth MD; Whittaker KM; Choi R; Tashkin DP; Baldwin GC
    J Leukoc Biol; 2005 Dec; 78(6):1198-203. PubMed ID: 16204638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.